About the Position
This is a research position, reporting to the Senior Director of Gene Transfer Technologies. The incumbent will be an experienced scientist in the gene editing and genetic engineering space and have expertise in emerging techniques and their implementation for cellular therapeutics. Candidates from academia and industry will be considered who have a proven track record in the conceptualization and execution of innovation projects utilizing these technologies. A publication record in peer-reviewed journals and scientific network for troubleshooting and advice is preferred.
The work entails interacting with outside collaborators at a highly technical level, leading tech transfer and in-house establishment of novel, state of the art gene transfer technologies and the manufacturing of cellular therapeutics. Upon gene transfer, cell products are tested for potency using kinetic bioassays, secretion of cytokines and expression of surface markers, with each assessment done using different assay platforms as listed under requirements below. Strong applicants will have experience in more than one of these analysis platforms.
Candidates should be comfortable in an early stage biotechnology environment and enjoy the enterprise activities and opportunities that accompany a growing company . It is expected that the candidate has a strong desire to help patients with devastating, rare, autoimmune diseases and is a good match for Cabaletta’s team-focused culture of feedback, continuous improvement and pursuit of excellence.